Cargando…
A novel CEST-contrast nanoagent for differentiating the malignant degree in breast cancer
Different subtypes of breast cancer (BCC) have variable degrees of malignancy, which is closely related to their extracellular pH (pH(e)). Therefore, it is increasingly significant to monitor the extracellular pH sensitively to further determine the malignancy of different subtypes of BCC. Here, a l...
Autores principales: | Chen, Bixue, Meng, Xianfu, Wu, Wanlu, Zhang, Yuwen, Ma, Lin, Chen, Kaidong, Fang, Xiangming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167945/ https://www.ncbi.nlm.nih.gov/pubmed/37180024 http://dx.doi.org/10.1039/d3ra01006f |
Ejemplares similares
-
Development of novel polymeric nanoagents and their potential in cancer diagnosis and therapy runing title: Polymeric nanoagents for cancer theranostics
por: Huang, Ge, et al.
Publicado: (2022) -
ParaCEST Agents Encapsulated in Reverse Nano-Assembled Capsules (RACs): How Slow Molecular Tumbling Can Quench CEST Contrast
por: Farashishiko, Annah, et al.
Publicado: (2018) -
Advanced Polymeric Nanoagents for Oral Cancer Theranostics: A Mini Review
por: Zhang, Guan-Meng, et al.
Publicado: (2022) -
PEGylated rhenium nanoclusters: a degradable metal photothermal nanoagent for cancer therapy
por: Miao, Zhaohua, et al.
Publicado: (2019) -
Editorial: Recent advances in the design of novel polymer nanoagents for cancer theranostics
por: Ou, Hanlin, et al.
Publicado: (2023)